TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Duocort Pharma AB
Closing information (x1000 SEK)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
13,702
|
16,968
|
16,796 |
| Financial expenses |
6
|
643
|
0 |
| Earnings before taxes |
83,293
|
10,009
|
9,958 |
| EBITDA |
89,303
|
18,719
|
18,025 |
| Total assets |
178,944
|
95,651
|
92,542 |
| Current assets |
178,944
|
89,596
|
78,420 |
| Current liabilities |
17,824
|
666
|
6,900 |
| Equity capital |
161,120
|
94,985
|
85,642 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
90.0%
|
99.3%
|
92.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
607.9%
|
59.0%
|
59.3% |
| Return on assets (ROA) |
46.6%
|
11.1%
|
10.8% |
| Current ratio |
1003.9%
|
13452.9%
|
1136.5% |
| Return on equity (ROE) |
51.7%
|
10.5%
|
11.6% |
| Change turnover |
-3,266
|
172
|
-584 |
| Change turnover % |
-19%
|
1%
|
-3% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.